Effect of BI 1181181 on Midazolam, Warfarin, Omeprazole and Digoxin

NCT02345304 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Omeprazole
DRUG: Warfarin
DRUG: BI 1181181
DRUG: Midazolam
DRUG: Omeprazole
DRUG: BI 1181181
DRUG: Midazolam
DRUG: Midazolam
DRUG: Warfarin
DRUG: BI 1181181
DRUG: Digoxin
DRUG: Digoxin

Sponsor

Boehringer Ingelheim